Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. Provision of information on the organization of renal replacement therapy (RRT) in emergency medicine in hospitals of the Moscow Healthcare Department in the context of a pandemic of the novel coronavirus infection SARS-CoV2 (COVID-19). Materials and methods. The annual reports of the Chief External Expert in Nephrology for 2019-2020 were used. Data were obtained from 43 healthcare organizations (HCO) that use RRT methods, of which 33 HCO used RRT methods for patients with COVID-19. Results and conclusion. The COVID-19 pandemic led to a significant increase in the number of patients receiving RRT in the ICU, amounting to 9434 (of which with COVID-19 - 34.7%), which is 20.7% more than in 2019. Also, the number of patients with acute kidney injury (AKI) and “extrarenal indications” receiving RRT increased in 2020; an increase compared to 2019 amounted to 39.3 and 38.9%, respectively. There were 33.6 and 32.4% patients with COVID-19 in these groups, respectively. At the same time, the number of patients with CKD (55.2% - patients with COVID-19) who underwent RRT in the ICU decreased by 8.1% compared to 2019. The total number of RRT procedures in 2020 increased by 15% compared to 2019, with 34% of the total number for the year performed in patients with COVID-19 Compared to 2019, there was a statistically significant increase in mortality among ICU patients who received RRT in 2020, which amounted to 33.6% and 46.6%, respectively. The mortality rate of patients with COVID-19 was 62.5%, without COVID-19 - 38.1%.

全文:

受限制的访问

作者简介

Sergey Rey

N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department; Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: fanwal@mail.ru
Cand. Sci. (Med.), Senior Researcher; Leading Specialist a Moscow, Russia; Moscow, Russia

Nadezhda Vasina

Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: vasina-olimp@mail.ru
Cand. Sci. (Med.), Head of the Organizational and Methodological Department for Nephrology Moscow, Russia

Gennady Berdnikov

N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Healthcare Department

Email: berdnikovga@sklif.mos.ru
Cand. Sci. (Med.), Senior Researcher Moscow, Russia

Lyudmila Marchenkova

Research Institute for Healthcare Organization and Medical Management of the Moscow Healthcare Department

Email: marchen16@mail.ru
Cand. Sci. (Med.), Specialist Moscow, Russia

Oleg Kotenko

City Clinical Hospital № 52 of the Moscow Department of Healthcare

Email: olkotenko@yandex.ru
Cand. Sci. (Med.), Chief External Expert in Nephrology of the Moscow Healthcare Department, Head Moscow, Russia

参考

  1. Gagliardi I., Patella G., Michael A., et al. COVID-19 and the Kidney: From Epidemiology to Clinical Practice. J Clin Med. 2020;9(8):2506. Doi: 10.3390/ jcm9082506.
  2. Hansrivijit P., Qian C, Boonpheng B., et al. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. JInvestig Med. 2020;68(7):1261-1270. doi: 10.1136/jim-2020-001407.
  3. Shao M., Li X., Liu F., et al. Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and metaanalysis of 40 studies and 24,527 patients. Pharmacol Res. 2020;161:105107. doi: 10.1016/j.phrs.2020.105107.
  4. Gabarre P., Dumas G., Dupont T., et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020; 46(7):1339-1348. doi: 10.1007/s00134-020-06153-9
  5. Vinayagam S., Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. doi: 10.1016/jdfs.2020.118431.
  6. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
  7. Cunningham P.N., Dyanov H.M., Park P., et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol. 2002;168(11):5817-23. doi: 10.4049/jimmunol.168.11.5817.
  8. Su H., Yang M., Wan C., et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219-227. doi: 10.1016/j.kint.2020.04.003.
  9. Рей С.И., Васина Н.В., Марченкова Л.В., Котенко О.Н. Принципы организации заместительной почечной терапии в неотложной медицине Департамента здравоохранения города Москвы. Клиническая нефрология. 2019;(4):11-16. Doi: https://dx.doi.org/10.18565/nephrology.2019.4.11-16.
  10. Friedrich J.O., Wald R., Bagshaw S.M. et al. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16(4):R146. doi: 10.1186/cc11458.
  11. Robbins-Juarez S.Y., Qian L., King K.L., et al. Outcomes for Patients with COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis Kidney. Int Rep. 2020;5(8):1149-60. doi: 10.1016/j.ekir.2020.06.013.
  12. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-1012. doi: 10.1016/S0140-6736(20) 30566-3.
  13. Gabarre P., Dumas G., Dupont T., et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339-1348. doi: 10.1007/s00134-020-06153-9
  14. Pei G., Zhang Z., Peng J., et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol. 2020;31(6):1157-65. doi: 10.1681/ASN.2020030276.
  15. Muner M.B., Lukitsch I., Torres-Ortiz A.E., et al. Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans. Kidney360. 2020;1(7): 614-622. doi: 10.34067/KID.0002652020.
  16. ICNARC report on COVID-19 in critical care: England, Wales and Northern Ireland 26 March 2021. Available at: https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports/ICNARC_COVID-19_Report_2021-03-26.pdf.pdf [Accessed April 13, 2021].
  17. Flythe J.E., Assimon M.M., Tugman M.J., et al. STOP-COVID Investigators. Characteristics and Outcomes of Individuals with Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021;77(2):190-203.e1. doi: 10.1053/j.aakd.2020.09.003.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##